Moreover, METTL16 significantly inhibited bladder cancer cell proliferation and sensitized bladder cancer cells to cisplatin in vitro and in vivo via HIF-2α-PMEPA1-autophagy axis in a m6A manner, which might provide fresh insights into bladder cancer therapy. Here, PMEPA1 is linked to urinary bladder carcinoma.